Health Condition 1: E11- Type 2 diabetes mellitus
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Klick Inc
Eligibility
Inclusion criteria
Inclusion criteria: • Healthy participants and those with prediabetes or at risk of developing T2D will be screened and classified according to scores from the CANRISK Canadian Diabetes Risk Questionnaire (https://www.healthycanadians.gc.ca/en/canrisk) • Participants who are diagnosed with T2D must have a confirmation according to their latest medical records from a certified physician • Participants who are treated for T2D must only be taking Metformin, and not insulin or other medications, which may strongly control glucose levels • No restrictions on gender or ethnicity will be implemented • Participants must speak English fluently (no restrictions on language accent) • Subjects willing to give written informed consent • Subjects able to comply with the study protocol • Women of child bearing potential must have a negative urine pregnancy test prior to study entry
Exclusion criteria
Exclusion criteria: • Any person below the age of 18 years or above the age of 60 years • Suspected or confirmed pregnancy • Currently breastfeeding • Diagnosis of any known chronic or acute medical disease other than T2D (e.g., cardiovascular disease, respiratory disease, influenza, pneumonia, etc.) • Diagnosis of any known neurological disease or psychological disorder of any kind (e.g., brain lesion, epilepsy, anxiety, eating disorder, mood disorder, sleep disorder, etc.) • Any implanted electrical medical device (e.g., pacemaker, insulin pump, deep brain stimulator, etc.) • Use of antibiotics in the three months prior to enrollment • Any person planning to undergo a Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or high-frequency electrical heat (diathermy) treatment during the duration of the study (as per restrictions of the FreeStyle Libre device)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Voice with respect to blood glucoseTimepoint: 14 days | — |
Secondary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Countries
India
Contacts
Public ContactPuneet Mittal
Mittal Global Clinical Trial Services
Outcome results
None listed